THE UNITED LABORATORIES INTERNATIONAL HOLDINGS LIMITED

Andere talen The United Laboratories International Holdings Limited

Aandelen

3933

KYG8813K1085

Farmaceutische producten

Beurs gesloten - Hong Kong S.E. Andere beurzen 09:08:13 04-12-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
10,92 ^HKD	+1,30%		+5,81%	+55,78%

15/11	United Laboratories International geeft meer dan 3,6 miljoen aandelen uit onder het Share Award Scheme	MT
28/10	Antibiotisch geneesmiddel van United Laboratories International slaagt voor consistentiebeoordeling door Chinese toezichthouder	MT

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

The United Laboratories International Issues Over 3.6 Million Shares Under Share Award Scheme	15/11
United Laboratories International Unit's Antibiotic Drug Passes Chinese Regulator's Consistency Evaluation	28/10
United Laboratories Unit's Amoxicillin Gets Generic Drug Status in China	17/10
The United Laboratories International Enrolls First Subject for Phase 2A Clinical Trial for Eye Drops for Dry Eye	14/10
The United Laboratories International Holdings Limited Announces the Application for Marketing of Insulin Degludec Injection	14/10
The United Laboratories International Holdings Limited Declares Interim Dividend for the Six Months Ended 30 June 2024, Payable on October 15, 2024	30/08
The United Laboratories H1 Profit Up 16% as Revenue Rises 4%	30/08
The United Laboratories International Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2024	29/08
The United Laboratories International Holdings Limited Provides Unaudited Consolidated Group Earnings Guidance for the Six Months Ended 30 June 2024	15/08
The United Laboratories International's Unit Drug Successfully Completes Clinical Trial Phase IA	13/08
The United Laboratories International Holdings Announces Its Subsidiary The United Bio-Technology Co., Ltd. Completes Phase Ia Clinical Trial of UBT251 Injection	12/08
The United Laboratories International Holdings Limited Declares Final Dividend for the Year Ended 31 December 2023, Payable on 24 July 2024	20/06
The United Laboratories International Holdings Limited Declares Special Dividend for the Year Ended 31 December 2023, Payable on 24 July 2024	20/06
Chinese drugmakers developing generic drugs of Novo Nordisk's Ozempic	06/06
Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China	06/06
United Laboratories Proposes Final, Special Dividend for 2023	08/05
The United Laboratories International Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	27/03
The United Laboratories International's 2023 Profit Rises on Higher Revenue	27/03
The United Laboratories International Holdings Limited Recommends Payment of Final Dividend for the Year Ended 31 December 2023	26/03
The United Laboratories International Holdings Limited Recommends Payment of Special Dividend for the Year Ended 31 December 2023	26/03
The United Laboratories International Forecasts Profit Surge in 2023	15/03
The United Laboratories International Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	14/03
United Laboratories Postpones EGM Due to Bad Weather	09-10-23
United Laboratories Subsidiary Gets US FDA Nod for Injectable for Diabetes; Shares Rise 8%	27-09-23
The United Laboratories International Holdings Limited Announces FDA Approval of IND for UBT251 Injection	26-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen The United Laboratories International Holdings Limited

Aandelen

3933

KYG8813K1085

Farmaceutische producten

Andere talen

Filters